REG - PureTech Health PLC - Transaction in Own Shares
06/02/2024 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240206:nRSF0913Ca&default-theme=true
RNS Number : 0913C PureTech Health PLC 06 February 2024
6 February 2024
PureTech Health plc
Transaction in Own Shares
PureTech Health PLC (the "Company") announces that it has purchased the
following number of its ordinary shares of one pence each through Jefferies
International Limited ("Jefferies"), as part of its Share Buyback Programme,
details of which were announced on 9 May 2022.
Date of purchase: 5 February 2024
Number of ordinary shares purchased: 67,637
Highest price paid per share: 194.40p
Lowest price paid per share: 189.00p
Volume weighted average price paid per share: 190.35p
PureTech intends to retain the purchased shares in treasury.
Following the above transaction, the Company will have 19,417,605 ordinary
shares in treasury and has 270,050,554 ordinary shares in issue (excluding
treasury shares). The total number of voting rights in the Company is
therefore 270,050,554 which may be used by shareholders in their calculations
to determine if they are required to notify their interest in, or a change to
their interest in, PureTech Health plc under the FCA's Disclosure Guidance and
Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as
incorporated into UK domestic law by the European Union (Withdrawal) Act 2018)
(the Market Abuse Regulation), detailed information about the individual
purchases is available below.
About PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated to giving life
to new classes of medicine to change the lives of patients with devastating
diseases. The Company has created a broad and deep pipeline through its
experienced research and development team and its extensive network of
scientists, clinicians and industry leaders that is being advanced both
internally and through its Founded Entities. PureTech's R&D engine has
resulted in the development of 27 therapeutics and therapeutic candidates,
including two (Plenity® and EndeavorRx®) that have received both U.S.
FDA clearance and European marketing authorization and a third (KarXT) that
has been filed for FDA approval. A number of these programs are being advanced
by PureTech or its Founded Entities in various indications and stages of
clinical development, including registration enabling studies. All of the
underlying programs and platforms that resulted in this pipeline of
therapeutic candidates were initially identified or discovered and then
advanced by the PureTech team through key validation points.
For more information, visit www.puretechhealth.com
(http://www.puretechhealth.com/) or connect with us on X, formerly known as
Twitter, @puretechh.
Contact:
PureTech
Investor Relations
IR@puretechhealth.com
Individual Transactions
Transaction Date Transaction Time Volume Price (GBp) Platform Transaction Reference Number
05/02/2024 08:10:54 542 194.4 XLON 00388476624TRLO0.1.1
05/02/2024 08:30:10 790 192.8 XLON 00388480894TRLO0.1.1
05/02/2024 08:30:10 1920 193 XLON 00388480895TRLO0.1.1
05/02/2024 08:33:22 100 191.8 XLON 00388481869TRLO0.1.1
05/02/2024 08:33:22 442 191.8 XLON 00388481870TRLO0.1.1
05/02/2024 08:39:26 1200 191.2 XLON 00388483562TRLO0.1.1
05/02/2024 08:39:26 600 191.2 XLON 00388483561TRLO0.1.1
05/02/2024 08:39:26 368 191.2 XLON 00388483563TRLO0.1.1
05/02/2024 08:59:36 19 192.4 XLON 00388489022TRLO0.1.1
05/02/2024 09:08:37 233 192.4 XLON 00388491619TRLO0.1.1
05/02/2024 09:08:38 233 191.8 XLON 00388491623TRLO0.1.1
05/02/2024 09:08:38 311 191.8 XLON 00388491624TRLO0.1.1
05/02/2024 09:08:38 184 191.8 XLON 00388491626TRLO0.1.1
05/02/2024 09:08:38 542 191.8 XLON 00388491625TRLO0.1.1
05/02/2024 09:08:38 2168 191.8 XLON 00388491627TRLO0.1.1
05/02/2024 09:08:44 119 192.2 XLON 00388491650TRLO0.1.1
05/02/2024 09:44:20 146 191.4 XLON 00388500718TRLO0.1.1
05/02/2024 09:44:20 54 191.4 XLON 00388500719TRLO0.1.1
05/02/2024 09:44:20 295 191.4 XLON 00388500720TRLO0.1.1
05/02/2024 09:44:20 523 191.4 XLON 00388500721TRLO0.1.1
05/02/2024 09:44:20 495 191.4 XLON 00388500722TRLO0.1.1
05/02/2024 09:44:20 542 191.4 XLON 00388500723TRLO0.1.1
05/02/2024 09:44:20 1198 191.4 XLON 00388500724TRLO0.1.1
05/02/2024 09:44:20 428 191.4 XLON 00388500725TRLO0.1.1
05/02/2024 09:44:20 1034 191.4 XLON 00388500726TRLO0.1.1
05/02/2024 09:44:20 119 191.2 XLON 00388500727TRLO0.1.1
05/02/2024 09:51:50 233 189 XLON 00388502689TRLO0.1.1
05/02/2024 09:51:50 2168 189 XLON 00388502690TRLO0.1.1
05/02/2024 09:54:00 471 189 XLON 00388503128TRLO0.1.1
05/02/2024 09:54:00 80 189 XLON 00388503130TRLO0.1.1
05/02/2024 09:54:00 41 189 XLON 00388503129TRLO0.1.1
05/02/2024 10:45:50 39 189.6 XLON 00388517976TRLO0.1.1
05/02/2024 11:52:50 47 190.8 XLON 00388536893TRLO0.1.1
05/02/2024 11:54:45 747 190.8 XLON 00388537416TRLO0.1.1
05/02/2024 11:54:56 27 190.8 XLON 00388537449TRLO0.1.1
05/02/2024 12:09:20 35 190.8 XLON 00388540689TRLO0.1.1
05/02/2024 12:15:45 92 190.4 XLON 00388542478TRLO0.1.1
05/02/2024 12:33:45 31 191 XLON 00388546677TRLO0.1.1
05/02/2024 12:36:57 77 191 XLON 00388547444TRLO0.1.1
05/02/2024 12:59:25 11 190.6 XLON 00388552714TRLO0.1.1
05/02/2024 12:59:25 42 190.6 XLON 00388552715TRLO0.1.1
05/02/2024 13:08:38 24 190.8 XLON 00388555331TRLO0.1.1
05/02/2024 13:08:38 131 190.8 XLON 00388555332TRLO0.1.1
05/02/2024 13:08:40 118 190.8 XLON 00388555358TRLO0.1.1
05/02/2024 13:09:14 13 190.8 XLON 00388555527TRLO0.1.1
05/02/2024 13:09:46 69 190.8 XLON 00388555900TRLO0.1.1
05/02/2024 13:09:56 12 190.8 XLON 00388555964TRLO0.1.1
05/02/2024 13:10:13 222 190.6 XLON 00388556103TRLO0.1.1
05/02/2024 13:10:13 495 190.6 XLON 00388556104TRLO0.1.1
05/02/2024 13:10:13 542 190.6 XLON 00388556105TRLO0.1.1
05/02/2024 13:10:13 1299 190.6 XLON 00388556106TRLO0.1.1
05/02/2024 13:10:13 15 190.6 XLON 00388556107TRLO0.1.1
05/02/2024 13:10:13 1322 190.6 XLON 00388556109TRLO0.1.1
05/02/2024 13:10:13 789 190.6 XLON 00388556108TRLO0.1.1
05/02/2024 13:10:13 119 190.6 XLON 00388556110TRLO0.1.1
05/02/2024 13:25:26 1626 190.2 XLON 00388560158TRLO0.1.1
05/02/2024 13:25:26 1022 190.2 XLON 00388560159TRLO0.1.1
05/02/2024 13:25:28 152 190.6 XLON 00388560171TRLO0.1.1
05/02/2024 13:25:55 109 189.8 XLON 00388560255TRLO0.1.1
05/02/2024 13:33:10 162 189.8 XLON 00388562306TRLO0.1.1
05/02/2024 13:33:10 881 189.8 XLON 00388562307TRLO0.1.1
05/02/2024 13:33:10 89 189.8 XLON 00388562308TRLO0.1.1
05/02/2024 13:33:10 54 189.8 XLON 00388562309TRLO0.1.1
05/02/2024 13:33:10 25 189.8 XLON 00388562310TRLO0.1.1
05/02/2024 13:33:10 91 189.8 XLON 00388562311TRLO0.1.1
05/02/2024 13:33:10 2168 189.8 XLON 00388562312TRLO0.1.1
05/02/2024 14:38:07 542 190 XLON 00388594295TRLO0.1.1
05/02/2024 14:53:19 233 190.6 XLON 00388612077TRLO0.1.1
05/02/2024 14:53:19 233 190.6 XLON 00388612078TRLO0.1.1
05/02/2024 14:53:19 555 190.6 XLON 00388612079TRLO0.1.1
05/02/2024 14:53:19 385 190.4 XLON 00388612080TRLO0.1.1
05/02/2024 14:53:19 157 190.4 XLON 00388612081TRLO0.1.1
05/02/2024 14:53:19 119 190.4 XLON 00388612083TRLO0.1.1
05/02/2024 14:53:19 542 190.6 XLON 00388612082TRLO0.1.1
05/02/2024 14:53:19 119 190.4 XLON 00388612084TRLO0.1.1
05/02/2024 15:00:11 42 190.6 XLON 00388619026TRLO0.1.1
05/02/2024 15:04:40 500 190.6 XLON 00388624587TRLO0.1.1
05/02/2024 15:04:40 53 190.6 XLON 00388624588TRLO0.1.1
05/02/2024 15:04:40 489 190.6 XLON 00388624589TRLO0.1.1
05/02/2024 15:19:06 233 189.8 XLON 00388645674TRLO0.1.1
05/02/2024 15:19:06 1626 189.8 XLON 00388645675TRLO0.1.1
05/02/2024 15:19:06 1034 189.8 XLON 00388645676TRLO0.1.1
05/02/2024 15:47:25 465 190.4 XLON 00388669633TRLO0.1.1
05/02/2024 15:47:25 408 190.2 XLON 00388669634TRLO0.1.1
05/02/2024 15:47:25 370 190.2 XLON 00388669635TRLO0.1.1
05/02/2024 15:47:25 2710 190.4 XLON 00388669636TRLO0.1.1
05/02/2024 15:47:25 119 190.2 XLON 00388669637TRLO0.1.1
05/02/2024 15:47:25 41 190.2 XLON 00388669638TRLO0.1.1
05/02/2024 15:47:40 174 190 XLON 00388669811TRLO0.1.1
05/02/2024 15:54:47 2710 189 XLON 00388675886TRLO0.1.1
05/02/2024 15:55:05 399 189.8 XLON 00388676356TRLO0.1.1
05/02/2024 15:55:57 2710 190 XLON 00388677308TRLO0.1.1
05/02/2024 16:04:59 1400 189.8 XLON 00388684880TRLO0.1.1
05/02/2024 16:21:07 60 189.4 XLON 00388697549TRLO0.1.1
05/02/2024 16:25:29 482 189.4 XLON 00388701010TRLO0.1.1
05/02/2024 16:25:29 98 189.4 XLON 00388701011TRLO0.1.1
05/02/2024 16:25:29 30 189.4 XLON 00388701018TRLO0.1.1
05/02/2024 16:27:03 397 189.4 XLON 00388702217TRLO0.1.1
05/02/2024 16:27:03 171 189.4 XLON 00388702218TRLO0.1.1
05/02/2024 16:27:03 88 189.4 XLON 00388702219TRLO0.1.1
05/02/2024 16:27:03 139 189.4 XLON 00388702220TRLO0.1.1
05/02/2024 16:27:03 86 189.4 XLON 00388702221TRLO0.1.1
05/02/2024 16:27:09 15 189.8 XLON 00388702349TRLO0.1.1
05/02/2024 16:27:14 1203 189.8 XLON 00388702405TRLO0.1.1
05/02/2024 16:27:14 41 189.8 XLON 00388702406TRLO0.1.1
05/02/2024 16:29:18 46 189.2 XLON 00388704106TRLO0.1.1
05/02/2024 16:29:25 32 189.2 XLON 00388704194TRLO0.1.1
05/02/2024 16:29:44 479 189.8 XLON 00388704830TRLO0.1.1
05/02/2024 16:29:44 479 189.8 XLON 00388704832TRLO0.1.1
05/02/2024 16:29:44 2609 189.8 XLON 00388704831TRLO0.1.1
05/02/2024 16:29:44 3088 189.8 XLON 00388704833TRLO0.1.1
05/02/2024 16:29:45 310 189.8 XLON 00388704849TRLO0.1.1
05/02/2024 16:29:45 33 189.8 XLON 00388704850TRLO0.1.1
05/02/2024 16:29:45 690 189.8 XLON 00388704851TRLO0.1.1
05/02/2024 16:29:45 1000 189.8 XLON 00388704852TRLO0.1.1
05/02/2024 16:29:45 1000 189.8 XLON 00388704853TRLO0.1.1
05/02/2024 16:29:45 55 189.8 XLON 00388704854TRLO0.1.1
05/02/2024 16:29:45 945 189.8 XLON 00388704855TRLO0.1.1
05/02/2024 16:29:45 1000 189.8 XLON 00388704856TRLO0.1.1
05/02/2024 16:29:45 1000 189.8 XLON 00388704857TRLO0.1.1
05/02/2024 16:29:45 1000 189.8 XLON 00388704861TRLO0.1.1
05/02/2024 16:29:45 77 189 XLON 00388704862TRLO0.1.1
05/02/2024 16:29:45 88 189.8 XLON 00388704863TRLO0.1.1
05/02/2024 16:29:45 542 189.8 XLON 00388704864TRLO0.1.1
05/02/2024 16:29:45 292 189.8 XLON 00388704865TRLO0.1.1
05/02/2024 16:29:46 1 189.8 XLON 00388704920TRLO0.1.1
05/02/2024 16:29:46 190 189.8 XLON 00388704928TRLO0.1.1
05/02/2024 16:29:46 1208 189.8 XLON 00388704931TRLO0.1.1
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSFLFLAFTIEIISRecent news on Puretech Health
See all newsREG - PureTech Health PLC - Total Voting Rights
AnnouncementREG - PureTech Health PLC - Final Results
AnnouncementREG - PureTech Health PLC - Notice of Results
AnnouncementRCS - PureTech Health PLC - PRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024
AnnouncementRCS - PureTech Health PLC - FDA Grants PRTC's LYT-200 Fast Track Designation
Announcement